These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 31966825

  • 1. Downregulation of serum miR-140-5p predicts poor prognosis of patients with colorectal cancer.
    Li J, Gao J, Tian W, Li Y, Zhang J.
    Int J Clin Exp Pathol; 2017; 10(9):9503-9508. PubMed ID: 31966825
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL, Chen YL, Ge ZZ, Qu YY, Cao Y, Kang ZX.
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [Abstract] [Full Text] [Related]

  • 3. Exosomal miR-6803-5p as potential diagnostic and prognostic marker in colorectal cancer.
    Yan S, Jiang Y, Liang C, Cheng M, Jin C, Duan Q, Xu D, Yang L, Zhang X, Ren B, Jin P.
    J Cell Biochem; 2018 May; 119(5):4113-4119. PubMed ID: 29240249
    [Abstract] [Full Text] [Related]

  • 4. Upregulated serum miR-675 predicts poor prognosis for colorectal cancer.
    Zhang R, Xu J, Zhao J, Liu F.
    Int J Clin Exp Pathol; 2017 May; 10(7):8043-8049. PubMed ID: 31966656
    [Abstract] [Full Text] [Related]

  • 5. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH, Kheirandish S, Sheikhha MH.
    Cancer Biomark; 2019 May; 24(3):291-297. PubMed ID: 30883340
    [Abstract] [Full Text] [Related]

  • 6. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer.
    Yan S, Han B, Gao S, Wang X, Wang Z, Wang F, Zhang J, Xu D, Sun B.
    Oncotarget; 2017 Sep 01; 8(36):60149-60158. PubMed ID: 28947960
    [Abstract] [Full Text] [Related]

  • 7. Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3 may serve as novel biomarkers for colorectal cancer.
    Wang L, Zhao Y, Xu M, Zhou F, Yan J.
    J BUON; 2019 Sep 01; 24(3):1120-1127. PubMed ID: 31424670
    [Abstract] [Full Text] [Related]

  • 8. Plasma miR-183-5p in colorectal cancer patients as potential predictive lymph node metastasis marker.
    Sanjabi F, Nekouian R, Akbari A, Mirzaei R, Fattahi A.
    J Cancer Res Ther; 2022 Sep 01; 18(4):921-926. PubMed ID: 36149141
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of serum miR-193b in colorectal cancer.
    Xu J, Zhao J, Zhang R.
    Int J Clin Exp Pathol; 2017 Sep 01; 10(9):9509-9514. PubMed ID: 31966826
    [Abstract] [Full Text] [Related]

  • 10. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y, Mu N.
    Ann Clin Biochem; 2017 Jan 01; 54(1):127-133. PubMed ID: 27166306
    [Abstract] [Full Text] [Related]

  • 11. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
    Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li Y, Li Z, Ng SS, Sung JJ, Shen L, Yu J.
    Oncogene; 2015 Jul 30; 34(31):4142-52. PubMed ID: 25362853
    [Abstract] [Full Text] [Related]

  • 12. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H, Yang Y, Zhao H, Yang X, Luo Y, Ren Y, Liu W, Li N.
    Tumour Biol; 2016 Jan 30; 37(1):447-53. PubMed ID: 26224475
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of exosome-encapsulated miR-548c-5p is associated with poor prognosis in colorectal cancer.
    Peng ZY, Gu RH, Yan B.
    J Cell Biochem; 2019 Feb 30; 120(2):1457-1463. PubMed ID: 30171732
    [Abstract] [Full Text] [Related]

  • 14. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.
    Yang L, Men WL, Yan KM, Tie J, Nie YZ, Xiao HJ.
    Eur Rev Med Pharmacol Sci; 2018 Aug 30; 22(15):4837-4845. PubMed ID: 30070320
    [Abstract] [Full Text] [Related]

  • 15. Serum miR-106b upregulation predicts poor prognosis in patients with colorectal cancer.
    Zhao Y, Ren Q, Zhu K.
    Int J Clin Exp Pathol; 2018 Aug 30; 11(8):4197-4204. PubMed ID: 31949814
    [Abstract] [Full Text] [Related]

  • 16. The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
    Zhao L, Yu H, Yi S, Peng X, Su P, Xiao Z, Liu R, Tang A, Li X, Liu F, Shen S.
    Oncotarget; 2016 Jul 19; 7(29):45370-45384. PubMed ID: 27248318
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
    Yan S, Liu G, Jin C, Wang Z, Duan Q, Xu J, Xu D.
    J Cell Physiol; 2018 Sep 19; 233(9):6660-6668. PubMed ID: 29206292
    [Abstract] [Full Text] [Related]

  • 18. Identification of miR-195-5p as a novel prognostic biomarker for colorectal cancer.
    Bayat A, Raad M, Sharafshah A, Ahmadvand M, Aminian H.
    Mol Biol Rep; 2022 Jul 19; 49(7):6453-6457. PubMed ID: 35587844
    [Abstract] [Full Text] [Related]

  • 19. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O, Kara M, Yumrutas O, Bozgeyik E, Bozgeyik I, Celik OI.
    Tumour Biol; 2016 May 19; 37(5):6637-45. PubMed ID: 26643896
    [Abstract] [Full Text] [Related]

  • 20. The diagnostic and prognostic value of serum miR-206 in colorectal cancer.
    Liu X, Zheng W, Zhang X, Dong M, Sun G.
    Int J Clin Exp Pathol; 2017 May 19; 10(7):7528-7533. PubMed ID: 31966596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.